ClinicalTrials.Veeva

Menu
A

American Oncology Network | Hematology Oncology Clinic

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Bevacizumab
Atezolizumab
SPd
Leucovorin
Sacituzumab
5-fluorouracil
Selinexor
Tiragolumab
Irinotecan
EloPd

Parent organization

This site is a part of American Oncology Network

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 8 total trials

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer (IMforte)

Study GO43104 is a Phase III, randomized, open-label, multicenter study of lurbinectedin in combination with atezolizumab compared with atezolizumab...

Active, not recruiting
Small-Cell Lung Cancer
Drug: Atezolizumab
Drug: Lurbinectedin

The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in combination wi...

Enrolling
Carcinoma, Hepatocellular
Drug: Tiragolumab
Other: Placebo

This study will evaluate the efficacy, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with selected B-ce...

Enrolling
Non-Hodgkin Lymphoma
Drug: Mosunetuzumab (Cohorts A-C)
Drug: Mosunetuzumab (Cohorts D-E)

This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of...

Enrolling
Multiple Myeloma
Drug: Selinexor
Drug: Elotuzumab

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to ful...

Enrolling
Metastatic Breast Cancer
Drug: Lasofoxifene in combination with abemaciclib
Drug: Fulvestrant in combination with abemaciclib

This is a Phase 2 randomized, open-label, two-part, multicenter study with a safety run-in to evaluate efficacy and safety of DKN-01 plus FOLFIRI/FOL...

Enrolling
Colorectal Adenocarcinoma
Colo-rectal Cancer
Drug: Bevacizumab
Drug: FOLFOX
Locations recently updated

The goal of this clinical study is to see if sacituzumab govitecan-hziy (SG) can improve life spans of people with HR+/HER2- metastatic breast cancer...

Enrolling
Locally Advanced or Unresectable Metastatic Breast Cancer
Stage IV Breast Cancer
Drug: Paclitaxel
Drug: Capecitabine

Trial sponsors

Roche logo
Genentech logo
Gilead Sciences logo
Ipsen logo
L
S
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems